Literature DB >> 4338117

Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats.

P Segal, P S Roheim, H A Eder.   

Abstract

The effects of clofibrate administration were studied in rats made hyperlipidemic by the feeding of diets high in sucrose. Within 12 hr of administration of clofibrate, there was a marked decrease in the concentration of serum high density lipoproteins but no change in the concentrations of the low and very low density lipoproteins. Between 2-4 days of treatment, the concentration of the very low density lipoproteins decreased whereas that of the low density lipoproteins was unchanged. In addition, the composition of the very low density lipoproteins was altered by clofibrate administration with a decrease in triglyceride and an increase in phospholipid content. The synthesis of high density lipoproteins, as measured by the incorporation of labeled amino acids, decreased within 12 hr of treatment. The synthesis of the very low density lipoproteins was increased during the first 2 days and then decreased slightly. The synthesis of low density lipoproteins did not change. The rate of removal of very low density lipoproteins was measured at various times from 0.5 to 8 days of treatment and was found to be elevated. It was concluded that in the hyperlipidemic sucrose-fed rat, administration of clofibrate results in a reduced level of very low density lipoproteins which may be due in part to enhancement of the rate of removal of this fraction.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338117      PMCID: PMC292310          DOI: 10.1172/JCI106964

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity.

Authors:  E L Tolman; H M Tepperman; J Tepperman
Journal:  Am J Physiol       Date:  1970-05

2.  Regulation of protein turnover in mammalian tissues.

Authors:  R T Schimke; R Ganschow; D Doyle; I M Arias
Journal:  Fed Proc       Date:  1968 Sep-Oct

3.  On the mechanism of action of atromid-S on triglyceride transport in man.

Authors:  E L Bierman; J D Brunzell; J D Bagdade; R L Lerner; W R Hazzard; D Porte
Journal:  Trans Assoc Am Physicians       Date:  1970

4.  The effect of heparin infusion on plasma triglyceride in vivo and in vitro with a method for calculating triglyceride turnover.

Authors:  D Porte; E L Bierman
Journal:  J Lab Clin Med       Date:  1969-04

5.  Fine structure of the His bundle.

Authors:  T N James; L Sherf
Journal:  Circulation       Date:  1971-07       Impact factor: 29.690

6.  Isolation and characterization of subunit polypeptides from apoproteins of rat serum lipoprotein.

Authors:  S Koga; L Bolis; A M Scanu
Journal:  Biochim Biophys Acta       Date:  1971-05-25

7.  The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.

Authors:  M A Mishkel; W F Webb
Journal:  Biochem Pharmacol       Date:  1967-05       Impact factor: 5.858

8.  Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans.

Authors:  R J Havel; J P Kane; E O Balasse; N Segel; L V Basso
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

9.  Isolation and properties of lipoproteins from normal rat serum.

Authors:  S Koga; D L Horwitz; A M Scanu
Journal:  J Lipid Res       Date:  1969-09       Impact factor: 5.922

10.  Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons.

Authors:  T G Redgrave
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  7 in total

1.  Studies on the mechanism of action of halofenate.

Authors:  L R Mandel
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

2.  Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.

Authors:  B M Wolfe; J P Kane; R J Havel; H P Brewster
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

3.  Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.

Authors:  M O'Brien; S T Patel; A Mukhopadhyay; H A Newman; D R Feller; S S Kokrady; D T Witiak; R R Lanese; J C Rice
Journal:  Lipids       Date:  1981-12       Impact factor: 1.880

4.  Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals.

Authors:  A Mukhopadhyay; S T Patel; M O'Brien; S S Kokrady; H A Newman; D T Witiak; R R Lanese; J C Rice; D R Feller
Journal:  Lipids       Date:  1983-01       Impact factor: 1.880

5.  Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models.

Authors:  R C Cavestri; J A Minatelli; J R Baldwin; W Loh; D R Feller; H A Newman; C L Sober; D T Witiak
Journal:  Lipids       Date:  1981-01       Impact factor: 1.880

6.  Fatty liver induced in Zucker "fatty" (ff) rats by a semisynthetic diet rich in sucrose.

Authors:  P M Novikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

7.  Fatty liver induced in Zucker "fatty" (ff) rats by a semisynthetic diet rich in sucrose.

Authors:  P M Novikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.